PeptidePedia The community reference

Contributions of DulaglutideDug

User contributions·22 logged edits·page 1 of 1

Contributions by DulaglutideDug, newest first. This list covers edits recorded in the site's change log; the editor's lifetime total of 1,722 edits includes activity predating the current log.

  1. 22:24, 15 Jul 2026 (diff | hist) Amylin 5,795 ±0 state the substitution in one-letter code as well, per PP:MOS
  2. 12:41, 12 Jun 2026 (diff | hist) International nonproprietary name 4,356 ±0 m expand §Stems relevant here
  3. 04:11, 11 Jun 2026 (diff | hist) Dulaglutide 5,490 ±0 rm the comparison to a compound with no published head-to-head data
  4. 15:04, 6 Apr 2026 (diff | hist) Zhuhai Kerui Biotechnology 14,711 ±0 rm the comparison with another supplier; there is no common basis for it
  5. 18:48, 2 Apr 2026 (diff | hist) Aspiration risk under anaesthesia 4,681 ±0 add the time course: most of these events are early and transient
  6. 13:05, 13 Feb 2026 (diff | hist) Talk:Dulaglutide 611 +202 /* Is this a peptide article at all? */ reply
  7. 16:34, 25 Jan 2026 (diff | hist) Lixisenatide 4,195 ±0 m add category for the drug class
  8. 04:09, 9 Dec 2025 (diff | hist) Retatrutide 7,421 ±0 add the receptor targets to the lead sentence
  9. 10:52, 14 Sep 2025 (diff | hist) Oral semaglutide 4,349 ±0 rm duplicated pharmacokinetics — the same figures appear in the infobox
  10. 21:27, 20 Aug 2025 (diff | hist) Semaglutide 9,799 ±0 add the discontinued indication with its date
  11. 16:51, 10 Aug 2025 (diff | hist) Third-party testing 7,489 +583 add the laboratory accreditation status, or say plainly that it is not stated
  12. 19:22, 7 Jun 2025 (diff | hist) International nonproprietary name 4,000 +817 state the substitution in one-letter code as well, per PP:MOS
  13. 06:41, 20 Apr 2025 (diff | hist) International nonproprietary name 3,183 +38 m rm duplicated pharmacokinetics — the same figures appear in the infobox
  14. 02:16, 21 Feb 2025 (diff | hist) Oral semaglutide 3,519 ±0 fix the anchor on an internal link
  15. 07:12, 19 Jan 2025 (diff | hist) High-performance liquid chromatography 5,364 +646 m correct the flow rate — the source gives it in mL/min
  16. 14:43, 24 Nov 2024 (diff | hist) Glucagon 4,787 +590 m space between number and unit per PP:MOS
  17. 00:25, 14 Nov 2024 (diff | hist) Timeline of incretin therapeutics 2,352 ±0 expand §Physiology
  18. 23:55, 10 Nov 2024 (diff | hist) CagriSema 2,261 ±0 m reorder the analogues chronologically rather than alphabetically
  19. 00:06, 10 Nov 2024 (diff | hist) Lixisenatide 2,047 +276 m add the peptide length to the infobox
  20. 03:39, 16 Sep 2024 (diff | hist) Adverse effects of GLP-1 receptor agonists 3,137 ±0 correct the severity grading scale named
  21. 18:28, 7 Jul 2024 (diff | hist) Retatrutide 2,390 ±0 state which salt form the mass in the infobox refers to
  22. 11:07, 16 Jun 2024 (diff | hist) Tirzepatide 1,388 ±0 m add the excipient list from the labelling